LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
20 hedge funds and large institutions have $4.63M invested in Landos Biopharma, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$25.7K | |
| 2 | +$21.9K | |
| 3 | +$2.81K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.76K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$993 |
Top Sellers
| 1 | -$26K | |
| 2 | -$25.2K | |
| 3 | -$23.6K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$20.9K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$17.9K |